Replies to post #13419 on Sorrento Therapeutics Inc (SRNE)

[dia76ca]

With Ztlido sales possibly reaching $100 million this year and the Celularity investment worth about $200 million and new COVIMARK sales coming any day now ...I look forward to news about SEMDEXA, Mpro, COVISHIELD, ABIVERTINIB, ADNAB, DAR-T, SOFUSA, VIREX and several other programs advancing significantly this year!